87472214
Jun 1, 2017
Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, VIRAL DISEASES; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of ANTIMICROBIAL DISEASES; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Antibacterial pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for HUMAN THERAPEUTICS; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Ocular pharmaceuticals; Syringes sold filled with HUMAN THERAPEUTICS; Therapeutic pharmaceutical for the treatment of ANTIMICROBIAL DISEASES
Pharmaceuticals